Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-26

FDA Approved: GLIMEPIRIDE — Supplemental Application (Florida Pharmaceutical Products, LLC)

View source ↗

Summary

FDA approved a supplemental application for glimepiride from Florida Pharmaceutical Products, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glimepiride (glimepiride)

Snippet

SUPPL AP for GLIMEPIRIDE (GLIMEPIRIDE)